SQZ News and Press, SQZ Biotechnologies Company From 04/24/21

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

The following slide deck was published by SQZ Biotechnologies Company in conjunction with this event. For further details see: SQZ Biotechnologies (SQZ) Investor Presentation - Slideshow

SQZ enhanced APCs (eAPCs) demonstrated ability to meaningfully increase CD8 T cell response through incorporation of costimulatory molecules and cytokine signaling mRNA cargo in eAPCs enabled presentation of broader antigen repertoire, potentially expanding addressable patient...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Apri...

An update on the 20 life sciences companies Numenor Capital has profiled so far range from cell therapy companies like SQZ Biotech and Orchard Therapeutics to biologics platforms like Pandion. The best performing investment, over 170% return, so far has been Pandion Therapeutics that ...

SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in multiple investor conferences in April 2021. Armon Sharei, PhD, chief executive officer, will present a corporate o...

SQZ Biotechnologies (SQZ): FY GAAP EPS of -$9.35 misses by $5.90.Revenue of $20.99M (+4.4% Y/Y) beats by $2.93M.Press Release For further details see: SQZ Biotechnologies EPS misses by $5.90, beats on revenue

SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported full year 2020 financial results and recent business highlights. “In 2020, we experienced the most important moment in SQZ’s journey so fa...

SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that its team will present data on the next generation SQZ™ APCs and the broader applicability of the APC platform at the American Associati...

SQZ Biotechnologies is a cell therapy manufacturing company developing its own pipeline of medicines. The investment thesis is centered around a large market opportunity to treat HPV+ solid tumors and the margin of safety provided by SQZ's sizable partnership with Roche. SQZ is a ...